Inhaled insulin plus 2 oral agents (II2A) and inhaled insulin monotherapy (II) v 2 oral agents (2A) for type 2 diabetes*
| Outcomes at 12 weeks | Comparison | Event rates | RBI (95% CI) | NNT (CI) |
|---|---|---|---|---|
| *Abbreviations defined in glossary; event rates, RBI, RRI, NNT, NNH, and CI calculated from data in article. | ||||
| Haemoglobin A1c concentration <8% | II2A v 2A | 86% v 19% | 359% (207 to 609) | 2 (2 to 2) |
| II v 2A | 56% v 19% | 198% (93 to 372) | 3 (3 to 5) | |
| Haemoglobin A1c concentration <7% | II2A v 2A | 32% v 1% | 2972% (454 to 17536) | 4 (3 to 5) |
| II v 2A | 17% v 1% | 1500% (182 to 9260) | 7 (5 to 12) | |
| RRI (CI) | NNH (CI) | |||
| Hypoglycaemia | II2A v 2A | 78% v 8.3% | 836% (396 to 1734) | 2 (2 to 2) |
| II v 2A | 68% v 8.3% | 712% (327 to 1498) | 2 (2 to 3) | |
